BioNTech SE American Depositary Share (BNTX) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covi...
BioNTech SE American Depositary Share (BNTX) currently trades at a P/S ratio of 8.01 (range: 7.07–9.22, 72th percentile — above its historical average).
BioNTech SE American Depositary Share appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/S Ratio | 8.01 | 7.07 | 7.34 | 9.22 | 72th | above its historical average |